Molipaxin

Basic molipaxin information

• INN (international nonproprietary name): Trazodone
• Brand names available in the United Kingdom: Molipaxin; generic trazodone
• ATC code: N06AX05
• Forms and dosages: Capsules 50 mg, 100 mg; tablets 150 mg; oral solution 50 mg/5 mL
• Manufacturers in the United Kingdom: Angelini Pharma (originator) and generic manufacturers such as Teva, Sandoz and Mylan
• Registration status in the United Kingdom: Prescription-only medicine (POM)
• OTC / Rx classification: Prescription-only medicine (POM)

Everyday use and best practices

Molipaxin has sedative properties, so it is often taken in the evening or at night. This can help prevent daytime drowsiness. Follow the schedule given by your prescriber, as some regimens use divided daily doses.

Integrating molipaxin into your evening routine can be straightforward:

• Take it right before bedtime or as suggested by your healthcare provider.
• Establish a consistent time each night to take the medication.

Molipaxin is best taken with or just after food, which can reduce dizziness and stomach upset. Swallow the capsules or tablets with water.

Safety priorities

There are specific groups of patients who should avoid taking molipaxin. These include individuals with:

• A known hypersensitivity to trazodone.
• Recent myocardial infarction, where taking the medication may pose heightened risks.
• Concurrent use of monoamine oxidase inhibitors (MAOIs) or those who have recently stopped such medication.

Drowsiness and dizziness are common side effects associated with this medication. Therefore, it is advisable to:

• Avoid driving until you know how molipaxin affects you.
• Avoid operating heavy machinery or engaging in tasks that require full attention.

Dosage and adjustments

The general recommendation for adults managing depression typically starts at 150 mg per day, either in divided doses or as a single dose at night, and may be increased to a maximum of 300 mg per day in outpatients. Patients should consult their healthcare providers for specific adjustments tailored to their needs.

For special cases such as elderly patients or those with comorbidities, starting at a lower dose is crucial to mitigate potential side effects. It’s crucial to monitor progress closely and titrate the dose as needed. Regular consultations with healthcare professionals ensure safe usage.

What’s inside and how it works

Ingredients overview

Molipaxin's primary active ingredient is trazodone. It is available as capsules (50 mg, 100 mg), tablets (150 mg) and an oral solution (50 mg/5 mL).

Mechanism basics explained simply

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI). It acts on serotonin in the brain, which helps ease symptoms of depression and improve mood, and its sedative effect can help with sleep problems that accompany depression.

Main indications

Approved uses

Molipaxin is licensed in the UK for treating depression (with or without anxiety) and for anxiety.

Off-label uses in UK clinics

Healthcare professionals sometimes prescribe molipaxin off-label for conditions like chronic pain or insomnia, thanks to its sedative properties.

Interaction warnings

Food interactions

Patients should be cautious about dietary choices when taking molipaxin. Consuming alcohol alongside this medication can amplify side effects like dizziness or drowsiness.

Drug conflicts

It's crucial to be aware of potential drug interactions while using molipaxin. Patients are encouraged to consult their pharmacist about any medications currently being taken. Interactions include MAOIs, other antidepressants and serotonergic medicines (risk of serotonin syndrome), other sedatives, warfarin and some antihypertensives. Suspected side effects can be reported via the Yellow Card scheme.

Alternative choices

For patients exploring options beyond molipaxin, several antidepressants can be prescribed by the NHS:

NHS prescribing alternatives

• Mirtazapine: Effective for sleep problems with depression; may cause weight gain and sedation.
• Amitriptyline: Used for depression, chronic pain and sleep issues; has anticholinergic effects.
• Sertraline: Effective for depression and anxiety; possible gastrointestinal side effects.
• Paroxetine: Effective for anxiety disorders; withdrawal symptoms and sexual dysfunction are possible.

Consultation with a healthcare provider ensures the selection of the right antidepressant based on personal health profiles and preferences.

Regulation snapshot

Molipaxin is licensed in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of depression and anxiety. It is a prescription-only medicine (POM), and healthcare professionals monitor patient responses closely and adjust doses as necessary.

Frequently asked questions

Common questions about molipaxin:

• What are the common side effects of molipaxin? While generally well-tolerated, some may experience drowsiness, dry mouth, or dizziness. These side effects often lessen over time.
• How long can I take molipaxin? Long-term use is common, but dosage should be monitored regularly by a healthcare provider to assess ongoing efficacy and manage any side effects.
• Is there a risk of dependency? Molipaxin is not addictive, but stopping suddenly can cause withdrawal symptoms, so it is always advisable to reduce the dose gradually under medical supervision.

Guidelines for proper use

UK pharmacist counselling style

Key counselling points from pharmacists include:

• Taking dosages as prescribed, usually before bedtime to minimise sedation effects during the day.
• Monitoring for any side effects or changes in mood.
• Highlighting the importance of not abruptly stopping the medication without medical advice.

NHS patient support advice

The NHS offers resources to support individuals taking molipaxin:

• Access to community mental health services for ongoing monitoring and support.
• Online resources for managing mental health, such as self-help guides.
• Regular follow-ups with prescribed care teams to adjust treatment as needed.